Cardiovascular Diseases Clinical Trial
— FHHS: STEPOfficial title:
For Her Heart's Sake: A Clinical Trial to Assess Strategies to Enhance Participation in Cardiac Rehabilitation - STEP Project
Verified date | November 2015 |
Source | University of Manitoba |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Ethics Review Committee |
Study type | Interventional |
The goal of the proposed project is to determine if providing an intervention for women who decline the invitation to participate in standard cardiac rehabilitation programs (CRPs) will ultimately result in an increase their participation in CRPs.This study will evaluate outcomes of patients randomized to the FHHS STEP Program versus by non-STEP Program participants. The overall goal is to provide an alternate, introductory program that will engage, educate, and empower women following a cardiac event. Providing these women with the necessary personal resources will encourage and enable these women to take the step towards a cardiac rehabilitation program, which, in turn will ideally lead to a life-long commitment to heart health.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | October 2018 |
Est. primary completion date | March 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 50 Years and older |
Eligibility |
Inclusion Criteria: - Discharged from a Winnipeg Regional Health Authority (WRHA) facility; - Diagnosis of stable ischemic heart disease or acute coronary syndrome who have undergone revascularization via coronary artery bypass graft (CABG) surgery or elective percutaneous coronary intervention (PCI); - Diagnosis of valvular heart disease who have undergone valve surgery; - Diagnosis of stable ischemic or non-ischemic heart failure; - Able to read, write, and speak English; - Referred to and declined participation in a CRP in Winnipeg; - Willing and able to attend the STEP Program at the Victoria General Hospital. Exclusion Criteria: - Patients who have unstable or recent unstable cardiac syndrome, as defined by: - Severe heart failure (New York Heart Association Class IV) or angina (Canadian Cardiovascular Society Class IV) symptoms - Non-re-vascularized > triple vessel disease - Non-repaired severe valvular heart disease (aortic or mitral area < 1.0cm2 or mean gradient > 40 mmhg or > 10mmHg [millimetres of mercury] respectively) - Severe systolic heart failure (LVEF [left ventricular ejection fraction] < 30%) - High risk stress test - Exercise induced ventricular arrhythmias or recent (within the past 6 months) hospitalization for ventricular arrhythmias - Unstable arrhythmias (i.e., bradycardia; tachyarrhythmias) - Previous attendance in a CRP - Physical limitations that would preclude ability to walk - Cognitive impairment/deficits that would preclude participation in the STEP Project - Automatic internal cardiac defibrillator in situ - On waitlist for cardiac procedure (e.g., cardiac surgery; PCI) |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Manitoba | Reh-Fit Fitness Centre, Victoria General Hospital Foundation, Wellness Institute-Seven Oaks General Hospital |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cardiac Rehabilitation Program Enrolment | 3 yes/no questions: have you contacted a CRP; have you joined a CRP; do you plan to contact a CRP. if not, why not | 12 months | No |
Secondary | Short-Form-36 | 36 items re 8 dimensions: physical functioning (10 items), role limitations - physical (4 items), bodily pain (2 items), social functioning (2 items), general mental health (5 items), role limitations - emotional (3 items), vitality (4 items), general health perceptions, 5 items); coded to 0-100 score, with higher values representing more favourable states | baseline, 3, 6 and 12 months | No |
Secondary | Brief Symptom Inventory | 53 items; 5-point Likert scale (1-5); operationalizes concepts of anxiety, depression and hostility; 9 symptom domains, with higher scores indicating greater levels of distress. | baseline, 3, 6 and 12 months | No |
Secondary | General Self-Efficacy Scale | 10 items; scoring based on 4-point Likert scale (1-4), with higher scores reflecting higher perceived self-efficacy | baseline, 3, 6, 12 months | No |
Secondary | Multidimensional Self-Efficacy for Exercise Scale | 9 items; 11-point Likert scale (0-10), with higher scores reflecting higher task efficacy (3 items), coping efficacy (3 items) and scheduling efficacy (3 items | baseline, 3, 6 and 12 months | No |
Secondary | Enhancing Recovery in Coronary Heart Disease Social Support Instrument | 7 item scale is scored by totalling the six 5-point Likert scale items and a 7th item, which is scored 4 for 'yes' and 2 for 'no'. The scale captures structural, emotional and instrumental support | baseline, 3, 6 and 12 months | No |
Secondary | Stages of Change Questionnaire | 12 5-point-Likert scale (1-5) questions; Stages of readiness to change for each of the listed behaviors include 5 response items representing each of the stages of change (i.e., precontemplation, contemplation, preparation, action, and maintenance). | baseline, 3, 6 and 12 months | No |
Secondary | Health Resource Utilization Questionnaire | 4-items: self-reported number of contacts/visits with primary care provider, cardiologist, emergency department/Walk-in Clinic visits and hospital admissions. | 3, 6 and 12 months | No |
Secondary | International Physical Activity Questionnaire | 9-item, subjective 7 day recall of physical activity patterns | baseline, 3, 6 and 12 months | No |
Secondary | Client Satisfaction Questionnaire | intervention group only; 8 items; 4-point Likert scale; assesses general satisfaction with the health care services received; higher scores reflect higher satisfaction | 3 months | No |
Secondary | 6-Minute Walk Test | total distanced walked in 6 minutes | baseline, 3, 6 and 12 months | No |
Secondary | Accelerometry | accelerometers monitor/measure physical activity/sedentary behaviours for a specified period of time (7 days). | baseline, 3, 6 and 12 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|